196
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel

, , , , &
Pages 265-270 | Received 21 Sep 2019, Accepted 09 Feb 2020, Published online: 28 Feb 2020

References

  • Aboudara M, Maldonado F. Update in the management of pleural effusions. Med Clin North Am. 2019;103(3):475–485.
  • Sahn SA. The value of pleural fluid analysis. Am J Med Sci. 2008;335(1):7–15.
  • Quinn T, Alam N, Aminazad A, et al. Decision making and algorithm for the management of pleural effusions. Thorac Surg Clin. 2013;23(1):11–16.
  • Shaw JA, Irusen EM, Diacon AH, et al. Pleural tuberculosis: a concise clinical review. Clin Respir J. 2018;12(5):1779–1786.
  • Bhatnagar R, Maskell N. The modern diagnosis and management of pleural effusions. BMJ. 2015;351:h4520.
  • Yang Y, Liu YL, Shi HZ. Diagnostic accuracy of combinations of tumor markers for malignant pleural effusion: an updated meta-analysis. Respiration. 2017;94(1):62–69.
  • Gu Y, Zhai K, Shi HZ. Clinical value of tumor markers for determining cause of pleural effusion. Chin Med J. 2016;129(3):253–258.
  • Koniari I, Koletti B, Apostolakis E. Vascular endothelial growth factor with tumour growth factor-beta, endostatin, proteinases or cytokines might be useful for differential diagnosis of pleural effusions. Interact Cardiovasc Thorac Surg. 2011;12(3):424–425.
  • Verma A, Phua CK, Sim WY, et al. Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion. Medicine. 2016;95(26):e3996.
  • Zhai K, Lu Y, Shi HZ. Tuberculous pleural effusion. J Thorac Dis. 2016;8(7):E486–94.
  • Chen KY, Feng PH, Chang CC, et al. Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion. Int J Gen Med. 2016;9:183–189.
  • Klimiuk J, Krenke R, Safianowska A, et al. Diagnostic performance of different pleural fluid biomarkers in tuberculous pleurisy. Adv Exp Med Biol. 2015;852:21–30.
  • Shu CC, Wang JY, Hsu CL, et al. Diagnostic role of inflammatory and anti-inflammatory cytokines and effector molecules of cytotoxic T lymphocytes in tuberculous pleural effusion. Respirology. 2015;20(1):147–154.
  • Kallner A. Bayes' theorem, the ROC diagram and reference values: definition and use in clinical diagnosis. Biochem Med. 2018;28(1):010101.
  • Michot J-M, Madec Y, Bulifon S, et al. Adenosine deaminase is a useful biomarker to diagnose pleural tuberculosis in low to medium prevalence settings. Diagn Microbiol Infect Dis. 2016;84(3):215–220.
  • Ji Q, Huang B, Wang M, et al. Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions. Exp Ther Med. 2014;7(4):778–784.
  • Esposito DL, Bollela VR, Feitosa AL, et al. Expression profiles of cytokine mRNAs in the pleural fluid reveal differences among tuberculosis, malignancies, and pneumonia-exudative pleural effusions. Lung. 2015;193:1001–1007.
  • Zeng N, Wan C, Qin J, et al. Diagnostic value of interleukins for tuberculous pleural effusion: a systematic review and meta-analysis. BMC Pulm Med. 2017;17(1):180.
  • Wang J, Liu J, Xie X, et al. The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions. BMC Pulm Med. 2017;17(1):168.
  • Valdes L, San-Jose E, Ferreiro L, et al. Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients. Clin Respir J. 2015;9:203–213.
  • Volarić D, Flego V, Žauhar G, et al. Diagnostic value of tumour markers in pleural effusions. Biochem Med. 2018;28(1):010706.
  • Yang L, Hu YJ, Li FG, et al. Analysis of cytokine levers in pleural effusions of tuberculous pleurisy and tuberculous empyema. Mediators Inflamm. 2016;2016:3068103.
  • Papageorgiou CV, Anastasopoulos A, Ploussi M, et al. Flow cytometry analysis of CD4 + IFN-γ+ T-cells for the diagnosis of mycobacterium tuberculosis infection. Cytometry B. 2016;90(3):303–311.
  • Tang Y, Zhang J, Huang H, et al. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion. BMC Infect Dis. 2019;19(1):55.
  • Li M, Wang H, Wang X, et al. Diagnostic accuracy of tumor necrosis factor-alpha, interferon-gamma, interleukin-10 and adenosine deaminase 2 in differential diagnosis between tuberculous pleural effusion and malignant pleural effusion. J Cardiothorac Surg. 2014;9(1):118.
  • Watanabe N, Ishii T, Kita N, et al. The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions. BMC Pulm Med. 2018;18(1):176.
  • Lee J, Yoo SS, Lee SY, Cha SI, et al. Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels. Infection. 2017;45(1):59–65.
  • Izhakian S, Wasser WG, Fox BD, et al. The diagnostic value of the pleural fluid c-reactive protein in parapneumonic effusions. Dis Markers. 2016;2016:7539780.
  • Servonnet A, Frederic C, Fargeau F, et al. Pleural adenosine deaminase cut-off value for the diagnosis of tuberculous pleural effusion using the diazyme assay. Hong Kong Med J. 2018;24:207.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.